BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7432691)

  • 1. ["Clinical clearance" and "weekly clearance" of urea in periodical hemodialytic treatment].
    Ghezzi PM; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(39):2821-3. PubMed ID: 7432691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new approach to the treatment of renal failure.
    Rosin RD
    Ann R Coll Surg Engl; 1978 Mar; 60(2):99-107. PubMed ID: 637497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dialysis treatment of chronic kidney insufficiency in the uremic phase. Indications and limitations].
    Garini G; Savazzi G; Arisi L
    Recenti Prog Med; 1986 Sep; 77(9):440-3. PubMed ID: 3797795
    [No Abstract]   [Full Text] [Related]  

  • 4. The prescription of peritoneal dialysis.
    Tzamaloukas AH; Raj DS; Onime A; Servilla KS; Vanderjagt DJ; Murata GH
    Semin Dial; 2008; 21(3):250-7. PubMed ID: 18248525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of small solute clearance in hemodialysis.
    Huang Z; Clark WR; Gao D
    Semin Dial; 2005; 18(1):30-5. PubMed ID: 15663761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple equations for protein catabolic rate determination from pre dialysis and post dialysis blood urea nitrogen.
    Garred LJ; Barichello DL; Canaud BC; McCready WG
    ASAIO J; 1995; 41(4):889-95. PubMed ID: 8589472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved urea clearance raises the BUN in continuous peritoneal dialysis.
    Baltzan MA; Shoker AA; Baltzan RB; Pylypchuk GB
    Clin Nephrol; 1996 Mar; 45(3):183-7. PubMed ID: 8706360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2002; 18():62-7. PubMed ID: 12402589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD.
    Keshaviah P
    Kidney Int Suppl; 1993 Feb; 40():S28-38. PubMed ID: 8445836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremia and adequate dialysis treatment.
    Acchiardo SR
    Semin Nephrol; 1994 May; 14(3):274-81. PubMed ID: 8036362
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
    Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
    Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the treatment of the dialysis patient: a painful lesson.
    Depner TA
    Semin Nephrol; 1997 Jul; 17(4):285-97. PubMed ID: 9241714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea kinetics and intermittent dialysis prescription in small animals.
    Cowgill LD
    Vet Clin North Am Small Anim Pract; 2011 Jan; 41(1):193-225. PubMed ID: 21251518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification.
    Zsom L; Zsom M; Fulop T; Flessner MF
    Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxalate behavior in patients undergoing periodic hemodialytic treatments].
    Zucchelli P; Fusaroli M; Sasdelli M; Stallone C
    Minerva Nefrol; 1970; 17(6):184-6. PubMed ID: 5516052
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodialysis with on-line monitoring equipment: tools or toys?
    Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
    Nephrol Dial Transplant; 2005 Jan; 20(1):22-33. PubMed ID: 15632348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical considerations on molecular transport in dialysis and sorbent therapy for uremia.
    Gotch FA; Farrell PC; Sargent J
    J Dial; 1976-1977; 1(2):105-44. PubMed ID: 1052290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F
    Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.